1882O RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III study

Autor: Sheng, X., Ye, M., Zou, Q., Chen, P., He, Z., Wu, B., He, D., He, C., Xue, X., Ji, Z., Chen, H., Zhang, S., Liu, Y., Zhai, W., Zhang, X., Fu, C., Xu, D., Qiu, M., Huang, Y., Guo, J.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S1011-S1012
Databáze: ScienceDirect